This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: MOTION Trial - Updated Efficacy & Safety of Vimseltinib in Patients With Tenosynovial Giant Cell Tumor

16 views
September 25, 2024
0 Comments
Login to view comments. Click here to Login